Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

DRMADermata Therapeutics, Inc.

Nasdaq · CIK 0001853816
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts221

Identity from submissions API

NameDermata Therapeutics, Inc.
CIK0001853816
TickersDRMA
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858)-223-0882
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Dermata Therapeutics, Inc. (2021-04-02T04:00:00.000Z → 2026-11-17T05:00:00.000Z)
Business address
3525 DEL MAR HEIGHTS RD., #322
SAN DIEGO
CA
92130
CA
Mailing address
3525 DEL MAR HEIGHTS RD., #322
SAN DIEGO
CA
92130
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

374 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 8-K 8-K 8.01 0001493152-26-052715 001-40739 261564060 34 199883 1 1
2026-11-10 10-Q 10-Q 0001493152-26-050967 001-40739 261540352 34 6135404 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001493152-26-050964 001-40739 261540314 34 340771 1 1
2026-11-02 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-002901 005-92822 261512898 34 33812
2026-10-29 8-K 8-K 8.01 0001493152-26-049312 001-40739 261502972 34 204352 1 1
2026-10-21 424B3 424B3 0001493152-26-047911 333-299391 261476054 33 176486
2026-10-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003304 333-299391 261474063 33 1740
2026-10-09 S-3 S-3 0001493152-26-046518 333-299391 261452955 33 445999 1 1
2026-08-18 4 4 0001493152-26-039048 22677
2026-08-18 4 4 0001493152-26-039046 11347
2026-08-17 25-NSE xslF25X02/primary_doc.xml 0001354457-26-000799 001-40739 261286936 34 2976
2026-08-17 8-K 8-K 1.01,3.02,8.01,9.01 0001493152-26-038647 001-40739 261284920 34 1157502 1 1
2026-08-11 10-Q 10-Q 0001493152-26-037127 001-40739 261263204 34 5389920 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001493152-26-037124 001-40739 261263172 34 321101 1 1
2026-08-05 8-K 8-K 8.01 0001493152-26-036109 001-40739 261241452 34 252997 1 1
2026-06-16 4 4 0001493152-26-028884 5393
2026-06-04 S-8 S-8 0001493152-26-027275 333-296494 261065179 33 350560 1 1
2026-06-01 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-026642 005-92822 261051595 34 12494
2026-05-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001810 333-291740 261046917 33 1740
2026-05-29 424B3 424B3 0001493152-26-026446 333-291740 261046268 33 404629
2026-05-27 8-K 8-K 5.02,5.07,9.01 0001493152-26-025441 001-40739 261027254 34 293937 1 1
2026-05-27 CORRESP filename1.htm 0001493152-26-025407 10755
2026-05-22 S-3/A S-3/A 0001493152-26-025073 333-291740 261015055 33 622864 1 1
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-055876 005-92822 26974106 34 11632
2026-05-13 10-Q 10-Q 0001493152-26-022719 001-40739 26973287 34 4809254 1 1
2026-05-13 8-K 8-K 2.02,9.01 0001493152-26-022710 001-40739 26973203 34 685258 1 1
2026-04-22 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-001059 005-92822 26884066 34 20659
2026-04-17 ARS ARS 0001493152-26-017912 001-40739 26872532 34 2769114
2026-04-17 DEFA14A DEFA14A 0001493152-26-017911 001-40739 26872511 34 1022286
2026-04-17 DEF 14A DEF 14A 0001493152-26-017909 001-40739 26872492 34 2503330 1 1
2026-04-07 PRE 14A PRE 14A 0001493152-26-015348 001-40739 26842372 34 2503132 1 1
2026-03-26 10-K 10-K 0001493152-26-012992 001-40739 26799477 34 9237169 1 1
2026-03-26 8-K 8-K 2.02,9.01 0001493152-26-012991 001-40739 26799450 34 323266 1 1
2026-03-17 4 4 0001493152-26-010630 5344
2026-02-25 8-K 8-K 5.02 0001493152-26-008037 001-40739 26678478 34 250424 1 1
2026-02-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-26-007792 005-92822 26667090 34 8655
2026-02-18 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001308 005-92822 26649458 34 10563
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001248 005-92822 26645096 34 10492
2026-02-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-26-000261 005-92822 26612701 34 21708
2026-02-03 8-K 8-K 4.01,9.01 0001493152-26-004905 001-40739 26592829 34 262942 1 1
2026-02-02 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-26-004801 005-92822 26589373 34 8790
2026-01-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000354 333-292885 26580318 33 1739
2026-01-29 424B3 424B3 0001493152-26-004247 333-292885 26579265 33 257718
2026-01-27 CORRESP filename1.htm 0001493152-26-003812 13763
2026-01-27 UPLOAD filename1.pdf 0000000000-26-000945 333-292885 40048
2026-01-27 8-K 8-K 8.01,9.01 0001493152-26-003715 001-40739 26562213 34 298471 1 1
2026-01-27 424B5 424B5 0001493152-26-003706 333-268383 26562079 33 16548
2026-01-22 S-3 S-3 0001493152-26-003259 333-292885 26552393 33 532977 1 1
2026-01-08 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-26-000967 005-92822 26519611 34 14399
2026-01-07 D xslFormDX01/primary_doc.xml 06b 0001493152-26-000797 021-569228 26515742 33 14923
2026-01-06 4 xslF345X05/ownership.xml 0001493152-26-000698 5700
2026-01-06 4 xslF345X05/ownership.xml 0001493152-26-000703 5667
2026-01-06 4 4 0001493152-26-000699 5567
2026-01-06 4 xslF345X05/ownership.xml 0001493152-26-000704 5564
2026-01-06 4 4 0001493152-26-000697 5590
2026-01-06 4 xslF345X05/ownership.xml 0001493152-26-000702 5507
2026-01-06 4 4 0001493152-26-000696 5493
2026-01-06 4 4 0001493152-26-000701 5494
2026-01-06 4 xslF345X05/ownership.xml 0001493152-26-000695 5555
2026-01-06 4 4 0001493152-26-000700 5555
2026-01-06 4 4 0001493152-26-000694 5581
2026-01-02 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-26-000486 005-92822 26503011 34 21431
2025-12-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-003402 005-92822 251614489 34 31880
2025-12-29 4 xslF345X05/ownership.xml 0001493152-25-029470 16414
2025-12-29 4 xslF345X05/ownership.xml 0001493152-25-029468 27049
2025-12-29 8-K 8-K 1.01,3.02,8.01,9.01 0001493152-25-029364 001-40739 251609173 34 1330452 1 1
2025-11-24 S-3 S-3 0001493152-25-024720 333-291740 251509361 33 1812647 1 1
2025-11-18 8-K 8-K 1.02 0001493152-25-023942 001-40739 251492322 34 255296 1 1
2025-11-14 10-Q 10-Q 0001493152-25-023474 001-40739 251486224 34 4793045 1 1
2025-11-14 8-K 8-K 2.02,7.01,9.01 0001493152-25-023419 001-40739 251485851 34 328464 1 1
2025-11-07 8-K 8-K 8.01,9.01 0001493152-25-021255 001-40739 251462618 34 299773 1 1
2025-11-07 424B5 424B5 0001493152-25-021254 333-268383 251462589 33 13883
2025-09-17 8-K 8-K 8.01 0001493152-25-013815 001-40739 251318741 34 271374 1 1
2025-09-10 8-K 8-K 8.01 0001493152-25-012952 001-40739 251304702 34 254138 1 1
2025-08-25 8-K 8-K 8.01 0001641172-25-025405 001-40739 251251719 34 252394 1 1
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003583 005-92822 251222137 34 10349
2025-08-13 10-Q 10-Q 0001641172-25-023572 001-40739 251212689 34 4429366 1 1
2025-08-13 8-K 8-K 2.02,7.01,9.01 0001641172-25-023570 001-40739 251212663 34 314291 1 1
2025-07-30 8-K 8-K 3.03,5.03,9.01 0001641172-25-021501 001-40739 251164194 34 283216 1 1
2025-07-16 8-K 8-K 5.07 0001641172-25-019760 001-40739 251125812 34 273333 1 1
2025-07-07 8-K 8-K 3.01 0001641172-25-018042 001-40739 251108956 34 258536 1 1
2025-06-05 8-K 8-K 4.01,9.01 0001641172-25-013823 001-40739 251027559 34 260054 1 1
2025-06-02 ARS ARS 0001641172-25-013239 001-40739 251015016 34 2091060
2025-06-02 DEFA14A DEFA14A 0001641172-25-013238 001-40739 251014980 34 4926959
2025-06-02 DEF 14A DEF 14A 0001641172-25-013237 001-40739 251014938 34 1293716
2025-05-23 PRE 14A PRE 14A 0001641172-25-012257 001-40739 25982090 34 1671162
2025-05-21 8-K 8-K 7.01,8.01 0001641172-25-011873 001-40739 25971019 34 260745 1 1
2025-05-16 8-K 8-K 3.01 0001641172-25-011286 001-40739 25960640 34 271144 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002251 005-92822 25951935 34 10501
2025-05-14 8-K 8-K 2.02,7.01,9.01 0001641172-25-010112 001-40739 25942979 34 311928 1 1
2025-05-14 10-Q 10-Q 0001641172-25-010111 001-40739 25942975 34 4585300 1 1
2025-05-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-041511 005-92822 25930255 34 11186
2025-04-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001212 333-286547 25863377 33 1739
2025-04-23 424B3 form424b3.htm 0001641172-25-005881 333-286547 25862399 33 154470
2025-04-21 CORRESP filename1.htm 0001641172-25-005582 13227
2025-04-21 UPLOAD filename1.pdf 0000000000-25-004185 333-286547 40086
2025-04-15 S-3 FORM S-3 0001654954-25-004304 333-286547 25839723 33 292320
2025-04-15 8-K FORM 8-K 7.01,8.01,9.01 0001654954-25-004265 001-40739 25837692 34 216655 1 1
2025-04-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001641172-25-003085 005-92822 25819982 34 10932
2025-04-03 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001641172-25-002621 005-92822 25811276 34 10562
2025-03-28 8-K FORM 8-K 1.01,3.02,3.03,9.01 0001654954-25-003552 001-40739 25787419 34 539938 1 1
2025-03-27 8-K FORM 8-K 7.01,8.01,9.01 0001654954-25-003372 001-40739 25775385 34 224984 1 1
2025-03-25 8-K FORM 8-K 3.01 0001654954-25-003305 001-40739 25769442 34 173061 1 1
2025-03-17 8-K FORM 8-K 2.02,7.01,9.01 0001654954-25-002886 001-40739 25744698 34 241518 1 1
2025-03-17 10-K FORM 10-K 0001654954-25-002885 001-40739 25744617 34 6693166 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001304 005-92822 25631368 34 10508
2025-02-13 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-006502 005-92822 25622030 34 13459
2025-02-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000328 333-284603 25595224 33 1746
2025-02-05 424B3 424B3 0001654954-25-001172 333-284603 25594636 33 199936
2025-02-04 D/A xslFormDX01/primary_doc.xml 06b 0001493152-25-004861 021-536542 25588576 33 14580
2025-02-03 CORRESP filename1.htm 0001654954-25-001100 8195
2025-02-03 UPLOAD filename1.pdf 0000000000-25-001141 333-284603 40114
2025-01-30 S-3 S-3 0001654954-25-000940 333-284603 25573794 33 324148
2025-01-28 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-007608 005-92822 25565848 34 15738
2025-01-28 D xslFormDX01/primary_doc.xml 06b 0001493152-25-004008 021-536542 25565308 33 14485
2025-01-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-003484 005-92822 25551467 34 13449
2025-01-23 4 FORM 4 0001654954-25-000693 7631
2025-01-23 4 PRIMARY DOCUMENT 0001654954-25-000692 7621
2025-01-23 4 PRIMARY DOCUMENT 0001654954-25-000691 12159
2025-01-23 4 PRIMARY DOCUMENT 0001654954-25-000690 10524
2025-01-23 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001654954-25-000681 001-40739 25550341 34 1046034 1 1
2025-01-21 8-K FORM 8-K 1.01,7.01,9.01 0001654954-25-000570 001-40739 25540488 34 466274 1 1
2025-01-14 4 FORM 4 0001654954-25-000414 5172
2025-01-14 4 PRIMARY DOCUMENT 0001654954-25-000413 5373
2025-01-14 4 FORM 4 0001654954-25-000412 5232
2025-01-14 4 FORM 4 0001654954-25-000411 5269
2025-01-14 4 PRIMARY DOCUMENT 0001654954-25-000410 5472
2025-01-14 4 PRIMARY DOCUMENT 0001654954-25-000409 5405
2025-01-14 4 FORM 4 0001654954-25-000400 5340
2025-01-14 4 FORM 4 0001654954-25-000399 5188
2025-01-14 4 FORM 4 0001654954-25-000398 5357
2025-01-14 4 PRIMARY DOCUMENT 0001654954-25-000397 5232
2025-01-14 4 FORM 4 0001654954-25-000396 5240
2024-11-14 SC 13G/A armistice-drma093024a1.htm 0001172661-24-005311 005-92822 241464140 34 90568
2024-11-14 8-K FORM 8-K 2.02,7.01,9.01 0001654954-24-014289 001-40739 241456023 34 257424 1 1
2024-11-13 10-Q FORM 10-Q 0001654954-24-014274 001-40739 241454504 34 3621633 1 1
2024-09-27 D xslFormDX01/primary_doc.xml 06b 0001493152-24-038572 021-525299 241335786 33 14408
2024-09-24 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-09-24 16:00:00 9999999995-24-002950 333-282223 241321194 33 1747
2024-09-24 424B3 424B3 0001654954-24-012245 333-282223 241320394 33 176060
2024-09-23 UPLOAD filename1.pdf 0000000000-24-010780 333-282223 40048
2024-09-23 CORRESP filename1.htm 0001654954-24-012156 7567
2024-09-19 S-3 FORM S-3 0001654954-24-012106 333-282223 241310921 33 301937
2024-09-17 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001654954-24-012031 001-40739 241305438 34 1058209 1 1
2024-08-07 S-8 FORM S-8 0001654954-24-010111 333-281338 241184597 33 109307
2024-08-07 8-K FORM 8-K 2.02,7.01,9.01 0001654954-24-010104 001-40739 241183634 34 275141 1 1
2024-08-07 10-Q FORM 10-Q 0001654954-24-010103 001-40739 241183603 34 3459322 1 1
2024-08-02 8-K FORM 8-K 8.01,9.01 0001654954-24-009903 001-40739 241172204 34 201567 1 1
2024-08-02 424B5 424B5 0001654954-24-009900 333-268383 241172184 33 12952
2024-07-15 424B3 424B3 0001654954-24-008937 333-280682 241117341 33 162262
2024-07-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-12 16:15:00 9999999995-24-002156 333-280682 241115759 33 1747
2024-07-10 CORRESP filename1.htm 0001654954-24-008789 8577
2024-07-08 UPLOAD filename1.pdf 0000000000-24-007677 333-280682 40062
2024-07-03 S-3 FORM S-3 0001654954-24-008609 333-280682 241100093 33 291509
2024-06-07 8-K FORM 8-K 1.01,9.01 0001654954-24-007532 001-40739 241030619 34 475473 1 1
2024-06-07 424B5 FORM 424B5 0001654954-24-007531 333-268383 241030601 33 470559
2024-06-05 8-K FORM 8-K 8.01 0001654954-24-007369 001-40739 241020927 34 169239 1 1
2024-05-24 8-K FORM 8-K 3.01 0001654954-24-006912 001-40739 24984281 34 169084 1 1
2024-05-17 8-K FORM 8-K 1.01,3.02,3.03,9.01 0001654954-24-006608 001-40739 24959710 34 537638 1 1
2024-05-15 10-Q FORM 10-Q 0001654954-24-006398 001-40739 24950516 34 3038678 1 1
2024-05-15 8-K FORM 8-K 2.02,7.01,9.01 0001654954-24-006396 001-40739 24950481 34 223110 1 1
2024-05-15 8-K FORM 8-K 3.01,8.01 0001654954-24-006312 001-40739 24947473 34 177690 1 1
2024-05-14 8-K FORM 8-K 3.03,5.03,9.01 0001654954-24-006133 001-40739 24941721 34 201611 1 1
2024-05-07 8-K FORM 8-K 5.02,5.07,9.01 0001654954-24-005715 001-40739 24923132 34 205668 1 1
2024-03-26 ARS ARS 0001654954-24-003661 001-40739 24784235 34 113070791
2024-03-26 DEFA14A DEFA 14A 0001654954-24-003658 001-40739 24784092 34 33850
2024-03-26 DEF 14A DEF 14A 0001654954-24-003656 001-40739 24783957 34 756953
2024-03-21 10-K FORM 10-K 0001654954-24-003501 001-40739 24771310 34 5709778 1 1
2024-03-21 8-K FORM 8-K 2.02,7.01,9.01 0001654954-24-003500 001-40739 24771293 34 238083 1 1
2024-03-04 PRE 14A PRE 14A 0001654954-24-002511 001-40739 24712163 34 747468
2024-02-14 SC 13G armistice-drma123123.htm 0001172661-24-001340 005-92822 24636910 34 90520
2024-01-12 8-K FORM 8-K 5.07 0001654954-24-000520 001-40739 24532100 34 183299 1 1
2024-01-05 4 FORM 4 0001654954-24-000300 4978
2024-01-05 4 FORM 4 0001654954-24-000299 5362
2024-01-05 4 FORM 4 0001654954-24-000298 5098
2024-01-05 4 FORM 4 0001654954-24-000297 4998
2024-01-05 4 FORM 4 0001654954-24-000296 4930
2024-01-05 4 PRIMARY DOCUMENT 0001654954-24-000295 5389
2024-01-05 4 PRIMARY DOCUMENT 0001654954-24-000294 5180
2024-01-05 4 PRIMARY DOCUMENT 0001654954-24-000293 5295
2024-01-05 4 PRIMARY DOCUMENT 0001654954-24-000292 5060
2024-01-05 4 PRIMARY DOCUMENT 0001654954-24-000291 5256
2024-01-05 4 FORM 4 0001654954-24-000290 5274
2023-12-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-12-15 16:30:00 9999999995-23-003661 333-275931 231492134 33 1747
2023-12-15 424B3 424B3 0001654954-23-015637 333-275931 231491185 33 146216
2023-12-13 CORRESP filename1.htm 0001654954-23-015475 8856
2023-12-13 UPLOAD filename1.pdf 0000000000-23-013569 40280
2023-12-08 DEF 14A DEF 14A 0001654954-23-015300 001-40739 231476437 34 215066
2023-12-07 S-3 FORM S-3 0001654954-23-015259 333-275931 231472405 33 270704
2023-11-29 PRE 14A PRE 14A 0001654954-23-014925 001-40739 231453314 34 214540
2023-11-17 8-K FORM 8-K 1.01,3.02,3.03,9.01 0001654954-23-014542 001-40739 231418630 34 555354 1 1
2023-11-16 8-K FORM 8-K 3.01 0001654954-23-014446 001-40739 231411868 34 172028 1 1
2023-11-09 10-Q FORM 10-Q 0001654954-23-014016 001-40739 231392422 34 3173591 1 1
2023-11-09 8-K FORM 8-K 2.02,4.01,7.01,9.01 0001654954-23-014015 001-40739 231392405 34 293786 1 1
2023-09-14 S-8 FORM S-8 0001654954-23-011891 333-274513 231255490 33 104182
2023-08-10 8-K FORM 8-K 2.02,7.01,9.01 0001654954-23-010489 001-40739 231159759 34 238202 1 1
2023-08-10 10-Q FORM 10-Q 0001654954-23-010487 001-40739 231159710 34 3144447 1 1
2023-08-03 8-K FORM 8-K 4.01,5.02,5.07,9.01 0001654954-23-010092 001-40739 231140613 34 199113 1 1
2023-07-27 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-07-27 16:30:00 9999999995-23-002202 333-273170 231120027 33 1698
2023-07-27 424B4 424B4 0001654954-23-009750 333-273170 231119200 33 175784
2023-07-25 CORRESP filename1.htm 0001654954-23-009659 6114
2023-07-14 UPLOAD filename1.pdf 0000000000-23-007558 40229
2023-07-12 DEFA14A DEFA14A 0001654954-23-009043 001-40739 231083334 34 19868
2023-07-07 S-1 FORM S-1 0001654954-23-008945 333-273170 231077017 33 343651
2023-06-23 ARS ARS 0001654954-23-008355 001-40739 231038113 34 128271027
2023-06-23 DEFA14A DEFA14A 0001654954-23-008354 001-40739 231038098 34 27978
2023-06-23 DEF 14A DEF 14A 0001654954-23-008352 001-40739 231037938 34 586074
2023-06-12 D xslFormDX01/primary_doc.xml 06b 0001654954-23-007925 021-483997 231009440 33 14693
2023-06-01 SC 13G SCHEDULE 13G 0001213900-23-045130 005-92822 23985733 34 96686
2023-05-25 424B5 424B5 0001654954-23-007244 333-268383 23962117 33 447592
2023-05-24 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001654954-23-007177 001-40739 23955070 34 882330 1 1
2023-05-11 10-Q FORM 10-Q 0001654954-23-006208 001-40739 23910988 34 2664263 1 1
2023-05-11 8-K FORM 8-K 2.02,7.01,9.01 0001654954-23-006209 001-40739 23910984 34 292144 1 1
2023-03-31 SC 13D/A SC 13D/A 0001654954-23-004104 005-92822 23787584 34 48397
2023-03-30 SC 13D/A FORM SC 13D/A 0001654954-23-003923 005-92822 23780674 34 48642
2023-03-28 10-K/A FORM 10-K/A 0001654954-23-003730 001-40739 23770786 34 324861 1 1
2023-03-28 8-K FORM 8-K 8.01 0001654954-23-003722 001-40739 23769534 34 165023 1 1
2023-03-21 424B3 424B3 0001654954-23-003198 333-264668 23747313 33 18270
2023-03-20 8-K FORM 8-K 1.01,7.01,9.01 0001654954-23-003181 001-40739 23746752 34 214759 1 1
2023-03-20 424B4 FORM 424B4 0001654954-23-003148 333-270195 23745036 33 267564
2023-03-16 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-03-16 13:00:00 9999999995-23-000594 333-270195 23740590 33 1697
2023-03-16 CORRESP filename1.htm 0001654954-23-002983 22950
2023-03-16 CORRESP filename1.htm 0001654954-23-002981 11761
2023-03-16 S-1/A FORM S-1/A 0001654954-23-002967 333-270195 23737396 33 748609
2023-03-15 S-1/A FORM S-1/A 0001654954-23-002876 333-270195 23732885 33 421397
2023-03-14 CORRESP filename1.htm 0001654954-23-002834 10557
2023-03-14 CORRESP filename1.htm 0001654954-23-002832 17971
2023-03-13 S-1/A FORM S-1/A 0001654954-23-002742 333-270195 23728120 33 1035775
2023-03-13 CORRESP filename1.htm 0001654954-23-002716 5414
2023-03-13 CORRESP filename1.htm 0001654954-23-002715 5887
2023-03-13 8-K FORM 8-K 3.03,5.03,9.01 0001654954-23-002711 001-40739 23726661 34 192555 1 1
2023-03-06 UPLOAD filename1.pdf 0000000000-23-002215 40284
2023-03-01 S-1 FORM S-1 0001654954-23-002273 333-270195 23694765 33 440782
2023-02-21 8-K FORM 8-K 2.02,7.01,9.01 0001654954-23-001927 001-40739 23648191 34 315868 1 1
2023-02-21 10-K FORM 10-K 0001654954-23-001926 001-40739 23648187 34 6644443 1 1
2023-02-08 8-K FORM 8-K 5.07 0001654954-23-001476 001-40739 23599074 34 172644 1 1
2023-01-18 SC 13D/A SC 13D/A 0001654954-23-000567 005-92822 23535034 34 43126
2023-01-13 DEF 14A DEF 14A 0001654954-23-000377 001-40739 23527303 34 250435
2023-01-05 4 FORM 4 0001654954-23-000148 5154
2023-01-05 4 PRIMARY DOCUMENT 0001654954-23-000147 5080
2023-01-05 4 PRIMARY DOCUMENT 0001654954-23-000146 5216
2023-01-03 PRE 14A PRE 14A 0001654954-23-000060 001-40739 23502280 34 198303
2022-12-29 RW RW 0001654954-22-017049 333-262536 221499009 NE 9440
2022-12-15 8-K FORM 8-K 3.01,8.01 0001654954-22-016569 001-40739 221464834 34 181266 1 1
2022-12-05 8-K FORM 8-K 7.01,8.01,9.01 0001654954-22-016099 001-40739 221443862 34 191499 1 1
2022-11-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-11-25 17:00:00 9999999995-22-003396 333-268383 221421033 33 1698
2022-11-22 CORRESP filename1.htm 0001654954-22-015659 8801
2022-11-22 UPLOAD filename1.pdf 0000000000-22-012672 40176
2022-11-15 S-3 FORM S-3 0001654954-22-015367 333-268383 221391204 33 1258521
2022-11-10 8-K FORM 8-K 2.02,7.01,9.01 0001654954-22-015036 001-40739 221378686 34 294452 1 1
2022-11-10 10-Q FORM 10-Q 0001654954-22-015035 001-40739 221378662 34 4889804 1 1
2022-10-07 4 PRIMARY DOCUMENT 0001654954-22-013530 4288
2022-10-07 4 PRIMARY DOCUMENT 0001654954-22-013529 4346
2022-10-07 4 PRIMARY DOCUMENT 0001654954-22-013528 7111
2022-10-07 4 PRIMARY DOCUMENT 0001654954-22-013527 4454
2022-10-07 4 PRIMARY DOCUMENT 0001654954-22-013526 5063
2022-10-07 4 PRIMARY DOCUMENT 0001654954-22-013525 4333
2022-09-23 8-K FORM 8-K 5.03,9.01 0001654954-22-012918 001-40739 221262378 34 172684 1 1
2022-08-26 S-8 FORM S-8 0001654954-22-011891 333-267115 221206016 33 142854
2022-08-15 10-Q FORM 10-Q 0001654954-22-011375 001-40739 221165956 34 4531051 1 1
2022-08-15 8-K FORM 8-K 2.02,7.01,9.01 0001654954-22-011373 001-40739 221165906 34 272794 1 1
2022-07-11 8-K FORM 8-K 5.03,5.07,9.01 0001654954-22-009535 001-40739 221077540 34 190191 1 1
2022-07-08 4 FORM 4 0001654954-22-009457 4304
2022-07-08 4 FORM 4 0001654954-22-009456 4363
2022-07-08 4 PRIMARY DOCUMENT 0001654954-22-009455 6410
2022-07-08 4 PRIMARY DOCUMENT 0001654954-22-009454 5064
2022-07-08 4 PRIMARY DOCUMENT 0001654954-22-009453 4334
2022-07-08 4 PRIMARY DOCUMENT 0001654954-22-009452 4455
2022-07-07 4 PRIMARY DOCUMENT 0001654954-22-009392 5194
2022-06-24 424B3 424B3 0001654954-22-008771 333-264668 221040884 33 56607
2022-06-24 8-K FORM 8-K 5.02 0001654954-22-008770 001-40739 221040824 34 163929 1 1
2022-06-22 8-K FORM 8-K 3.01 0001654954-22-008628 001-40739 221032794 34 165554 1 1
2022-06-01 DEFA14A DEFA14A 0001654954-22-007815 001-40739 22988105 34 46685
2022-06-01 DEF 14A DEF 14A 0001654954-22-007809 001-40739 22987613 34 557971
2022-05-20 PRE 14A PRE 14A 0001654954-22-007310 001-40739 22947571 34 506637
2022-05-19 424B3 424B3 0001654954-22-007212 333-264668 22942824 33 571784
2022-05-17 8-K FORM 8-K 8.01 0001654954-22-007063 001-40739 22934508 34 163033 1 1
2022-05-16 8-K FORM 8-K 2.02,7.01,9.01 0001654954-22-006969 001-40739 22928968 34 230251 1 1
2022-05-16 10-Q FORM 10-Q 0001654954-22-006966 001-40739 22928821 34 3890927 1 1
2022-05-13 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-05-13 16:00:00 9999999995-22-001473 333-264668 22925142 33 1697
2022-05-13 424B4 FORM 424B4 0001654954-22-006773 333-264668 22923863 33 2239466
2022-05-11 CORRESP filename1.htm 0001654954-22-006454 12770
2022-05-10 UPLOAD filename1.pdf 0000000000-22-005080 40175
2022-05-05 SC 13D/A formsc13da.htm 0001493152-22-012278 005-92822 22897449 34 77033
2022-05-04 S-1 FORM S-1 0001654954-22-005986 333-264668 22891616 33 6829865 1 1
2022-04-25 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001654954-22-005375 001-40739 22850282 34 934297 1 1
2022-04-08 4 xslF345X03/dermata_fm4apr72022.xml 0000905718-22-000572 4678
2022-04-08 4 xslF345X03/dermata_fm4apr72022.xml 0000905718-22-000570 4663
2022-04-08 4 xslF345X03/dermata_fm4apr72022.xml 0000905718-22-000568 5407
2022-04-08 4 xslF345X03/dermata_fm4apr72022.xml 0000905718-22-000566 4659
2022-04-08 4 xslF345X03/dermata_fm4apr72022.xml 0000905718-22-000564 4749
2022-04-08 4 xslF345X03/dermata_fm4apr72022.xml 0000905718-22-000562 6619
2022-03-28 8-K FORM 8-K 2.02,7.01,9.01 0001654954-22-003871 001-40739 22773295 34 317947 1 1
2022-03-28 10-K FORM 10-K 0001654954-22-003869 001-40739 22773291 34 6676103 1 1
2022-03-02 8-K FORM 8-K 8.01 0001654954-22-002423 001-40739 22705216 34 162780 1 1
2022-02-07 S-1/A FORM S-1/A 0001654954-22-001233 333-262536 22598470 33 342118
2022-02-04 FWP FWP 0001654954-22-001137 333-262536 22594280 34 18229200
2022-02-04 8-K FORM 8-K 8.01 0001654954-22-001134 001-40739 22594085 34 166168 1 1
2022-02-04 S-1 FORM S-1 0001654954-22-001132 333-262536 22594069 33 9467271 1 1
2022-01-14 4 xslF345X03/dermata_fm4jan122022.xml 0000905718-22-000113 5261
2022-01-14 3 xslF345X02/dermata_fm3jan122022.xml 0000905718-22-000111 8965
2022-01-13 8-K CURRENT REPORT 5.02,7.01,9.01 0001654954-22-000428 001-40739 22527956 34 188963 1 1
2022-01-11 DRS filename1.htm 0001654954-22-000352 377-05918 22522769 33 3186812
2022-01-05 4 xslF345X03/dermata_fm4jan32022.xml 0000905718-22-000054 5163
2022-01-05 4 xslF345X03/dermata_fm4jan32022.xml 0000905718-22-000052 5367
2022-01-05 4 xslF345X03/dermata_fm4jan32022.xml 0000905718-22-000050 5380
2022-01-05 4 xslF345X03/dermata_fm4jan32022.xml 0000905718-22-000048 5307
2022-01-05 4 xslF345X03/dermata_fm4jan32022.xml 0000905718-22-000046 5208
2022-01-05 4 xslF345X03/dermata_fm4jan32022.xml 0000905718-22-000044 5231
2022-01-05 4 xslF345X03/dermata_fm4jan32022.xml 0000905718-22-000042 5211
2022-01-05 4 xslF345X03/dermata_fm4jan32022.xml 0000905718-22-000040 5196
2022-01-05 4 xslF345X03/dermata_fm4jan32022.xml 0000905718-22-000038 5445
2022-01-05 4 xslF345X03/dermata_fm4jan32022.xml 0000905718-22-000036 11874
2021-12-10 S-8 FORM S-8 0001654954-21-013056 333-261606 211486353 33 138974
2021-12-10 8-K FORM 8-K 5.02,9.01 0001654954-21-013038 001-40739 211484747 34 13174882 1 1
2021-11-26 4 xslF345X03/dermata_fm4nov232021.xml 0000905718-21-001541 8800
2021-11-19 8-K CURRENT REPORT 7.01,8.01 0001654954-21-012446 001-40739 211426494 34 208743 1 1
2021-11-15 8-K FORM 8-K 2.02,7.01,9.01 0001654954-21-012224 001-40739 211411012 34 237861 1 1
2021-11-15 10-Q FORM 10-Q 0001654954-21-012206 001-40739 211410469 34 4877155 1 1
2021-09-27 10-Q QUARTERLY REPORT 0001654954-21-010437 001-40739 211281816 34 4255303 1 1
2021-09-27 8-K CURRENT REPORT 2.02,7.01,9.01 0001654954-21-010436 001-40739 211281729 34 139592
2021-09-01 4 xslF345X03/dermata_fm4sep121.xml 0000905718-21-001165 5257
2021-09-01 3 xslF345X02/dermata_fm3sep121.xml 0000905718-21-001163 8964
2021-09-01 424B3 424B3 0001193125-21-263325 333-256997 211230839 33 83491
2021-09-01 8-K 8-K 5.02,7.01,9.01 0001193125-21-263316 001-40739 211230554 34 71932
2021-08-27 SC 13D SC 13D 0000905718-21-001151 005-92822 211219951 34 65546
2021-08-27 SC 13D SC 13D 0000905718-21-001150 005-92822 211219904 34 70551
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001114 5219
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001112 29707
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001110 34623
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001108 26913
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001106 5239
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001104 6907
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001102 5171
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001100 5204
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001098 7604
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001096 8240
2021-08-17 4 xslF345X03/dermata_fm4aug172021.xml 0000905718-21-001094 48289
2021-08-16 424B4 424B4 0001193125-21-247886 333-256997 211179345 33 3189838
2021-08-13 POS EX POS EX 0001193125-21-246076 333-256997 211172313 33 39910
2021-08-12 SEC STAFF LETTER filename1.pdf 9999999997-21-004513 271893
2021-08-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-08-12 17:00:00 9999999995-21-003176 333-256997 211169523 33 1698
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001039 9873
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001037 8905
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001035 8887
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001033 8859
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001031 26136
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001029 18839
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001027 23437
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001025 31118
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001023 14083
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001021 18557
2021-08-12 3 xslF345X02/ownership.xml 0000905718-21-001019 13510
2021-08-12 S-1MEF S-1MEF 0001193125-21-244908 333-258772 211168820 33 51508
2021-08-12 CERT 8A_cert_DRMA.pdf 0001354457-21-000928 001-40739 211166364 34 732495
2021-08-11 8-A12B 8-A12B 0001193125-21-243542 001-40739 211164579 34 15481
2021-08-10 CORRESP filename1.htm 0001193125-21-241938 6551
2021-08-10 CORRESP filename1.htm 0001193125-21-241929 7120
2021-08-06 SEC STAFF LETTER filename1.pdf 9999999997-21-004479 275765
2021-08-06 S-1/A S-1/A 0001193125-21-238151 333-256997 211150355 33 3968543
2021-07-12 FWP FWP 0001193125-21-213147 333-256997 211086034 34 11125022
2021-07-09 CORRESP filename1.htm 0001193125-21-211508 13481
2021-07-09 S-1/A S-1/A 0001193125-21-211505 333-256997 211082121 33 3127353
2021-07-08 SEC STAFF LETTER filename1.pdf 9999999997-21-004072 272466
2021-07-08 UPLOAD filename1.pdf 0000000000-21-008446 43238
2021-07-02 CORRESP filename1.htm 0001193125-21-207683 15578
2021-07-02 S-1/A S-1/A 0001193125-21-207676 333-256997 211070694 33 3629171
2021-06-17 UPLOAD filename1.pdf 0000000000-21-007506 46252
2021-06-10 CORRESP filename1.htm 0001193125-21-187921 12489
2021-06-10 S-1 S-1 0001193125-21-187916 333-256997 211008919 33 4223491
2021-05-20 UPLOAD filename1.pdf 0000000000-21-006390 43387
2021-05-07 DRSLTR filename1.htm 0000950123-21-005604 33407
2021-05-07 DRS/A filename1.htm 0000950123-21-005603 377-04573 21904185 33 2756768
2021-04-29 UPLOAD filename1.pdf 0000000000-21-005494 58170
2021-04-02 DRS filename1.htm 0000950123-21-004193 377-04573 21802223 33 2761837

Latest XBRL company facts

One latest value per concept from companyfacts (221 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 4.93M 2026-11-09 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
dei EntityPublicFloat Entity Public Float USD 3.10M 2025-06-30 2025 FY 10-K 2026-03-26 0001493152-26-012992
ffd NetFeeAmt NetFeeAmt USD 677.25 2026-10-09 S-3 2026-10-09 0001493152-26-046518
ffd TtlFeeAmt TtlFeeAmt USD 677.25 2026-10-09 S-3 2026-10-09 0001493152-26-046518
ffd TtlOfferingAmt TtlOfferingAmt USD 7.78M 2026-10-09 S-3 2026-10-09 0001493152-26-046518
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-09 S-3 2026-10-09 0001493152-26-046518
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-09 S-3 2026-10-09 0001493152-26-046518
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.62M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 210,235 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 10,993 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 84.78M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 42,179 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 25,112 2025-04-01 2025-06-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023474
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 3.09M 2024-07-01 2024-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023474
us-gaap AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD -731,693 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023474
us-gaap AdvertisingExpense Advertising Expense USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.34M 2021-01-01 2021-03-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 10.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap Assets Assets USD 6.64M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap AssetsCurrent Assets, Current USD 6.43M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap Cash Cash USD 8.19M 2022-03-31 2022 Q1 10-Q 2022-05-16 0001654954-22-006966
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 4.82M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 12.07M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001654954-21-012206
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -4.28M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4.91 2024-05-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 10.05M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 10.05M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 13 2025-06-30 2025 Q2 10-Q 2025-08-13 0001641172-25-023572
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 4.93M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 4.93M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CommonStockValue Common Stock, Value, Issued USD 493 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CommonUnitAuthorized Common Unit, Authorized shares 102,074 2023-12-31 2023 FY 10-K 2024-03-21 0001654954-24-003501
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap ContractuallySpecifiedServicingFeesAmount Contractually Specified Servicing Fees, Amount USD 7.20M 2025-03-01 2025-03-31 2025 Q3 10-Q 2025-11-14 0001493152-25-023474
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 65.82M 2021-08-01 2021-08-17 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-03-28 0001654954-22-003869
us-gaap ConvertiblePreferredStockConvertedToOtherSecurities Convertible Preferred Stock Converted to Other Securities USD 1.25M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap ConvertibleSubordinatedDebt Convertible Subordinated Debt USD 3.00M 2020-10-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap CostOfRevenue Cost of Revenue USD 34,008 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap CumulativeEarningsDeficit Cumulative Earnings (Deficit) USD -65.70M 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 2.30M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 24,106 2021-08-01 2021-08-17 2024 Q1 10-Q 2024-05-15 0001654954-24-006398
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.8 2022-09-30 2022 Q3 10-Q 2022-11-10 0001654954-22-015035
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 100,000 2021-03-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 231,482 2021-01-01 2021-02-28 2022 Q3 10-Q 2022-11-10 0001654954-22-015035
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 60,000 2021-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 100,000 2024-06-30 2024 Q2 10-Q 2024-08-07 0001654954-24-010103
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 4 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 9,736 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 1,091 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 6,629 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 14.20M 2023-12-31 2023 FY 10-K 2024-03-21 0001654954-24-003501
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 71 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 200,000 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 1.30M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 25 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 9,736 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 2.62M 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 12,911 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap DepreciationExpenseOnReclassifiedAssets Depreciation Expense on Reclassified Assets USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0001654954-22-003869
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 1.20M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD 269,038 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001654954-21-012206
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.69 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001654954-21-012206
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.224 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.021 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.8 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 392,170 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 900,000 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 2.21M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001641172-25-023572
us-gaap GeneralPartnersOfferingCosts General Partners' Offering Costs USD 1.16M 2024-06-30 2024 Q2 10-Q 2024-08-07 0001654954-24-010103
us-gaap GrossProfit Gross Profit USD 40,129 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap IncomeTaxesPaid Income Taxes Paid USD 950 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 950 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1,690 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1,587 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 15 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -10 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 158 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -115,829 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 407,195 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 825,279 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 45,637 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 243,384 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -121,940 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap InterestExpense Interest Expense USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001654954-22-011375
us-gaap InterestExpenseSubordinatedNotesAndDebentures Interest Expense, Subordinated Notes and Debentures USD 180,434 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001654954-22-006966
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 161,357 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001654954-23-014016
us-gaap InterestIncomeOther Interest Income, Other USD 36,216 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001641172-25-010111
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001654954-22-011375
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 53,639 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap InventoryNet Inventory, Net USD 825,279 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 213,613 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 558,027 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 162,279 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap LegalFees Legal Fees USD 200,000 2026-08-18 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap Liabilities Liabilities USD 2.73M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 6.64M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.52M 2021-12-31 2021 FY 10-K 2022-03-28 0001654954-22-003869
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2021-12-31 2021 FY 10-K 2022-03-28 0001654954-22-003869
us-gaap LossContingencyDamagesPaidValue Loss Contingency, Damages Paid, Value USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap MalpracticeLossContingencyDiscountRate Malpractice Loss Contingency, Discount Rate pure 0.2 2021-01-01 2021-01-27 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap MarketingExpense Marketing Expense USD 700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 11.10M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap NetCashProvidedByUsedInDiscontinuedOperations Net Cash Provided by (Used in) Discontinued Operations USD 7.00M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001654954-22-015035
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 5.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -163,647 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -7.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -7.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -9.61M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap NotesPayable Notes Payable USD 1.15M 2020-10-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 1.25M 2021-01-27 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 311,000 2021-01-27 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 9.67M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap OperatingExpenses Operating Expenses USD 7.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -7.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 5.00M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 9.70M 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 37,499 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap OtherAssets Other Assets USD 45,637 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap OtherExpenses Other Expenses USD 700,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 3.59M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 86,967 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 7.00M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap PaymentForManagementFee Payment for Management Fee USD 225,000 2021-02-01 2021-02-28 2022 Q3 10-Q 2022-11-10 0001654954-22-015035
us-gaap PaymentsOfDerivativeIssuanceCosts Payments of Derivative Issuance Costs USD 70,000 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-13 0001641172-25-023572
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 91,352 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 163,647 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 2.29M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0001654954-22-003869
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 0 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-06-30 2026 Q2 10-Q 2026-08-11 0001493152-26-037127
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-06-30 2026 Q2 10-Q 2026-08-11 0001493152-26-037127
us-gaap PreferredUnitsIssued Preferred Units, Issued shares 5.22M 2021-07-30 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 583,314 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap PrepaidInsurance Prepaid Insurance USD 300,124 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap ProceedsFromCollectionOfOtherLoansHeldForSale Proceeds from Collection of Other Loans Held-for-sale USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0001654954-22-003869
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001654954-22-006966
us-gaap ProceedsFromFeesReceived Proceeds from Fees Received USD 10.00M 2021-01-01 2021-01-27 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 3.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001654954-22-006966
us-gaap ProceedsFromIssuanceOfSubordinatedLongTermDebt Proceeds from Issuance of Subordinated Long-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 87 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001654954-22-015035
us-gaap ProceedsFromLoanOriginations1 Proceeds from Loan Originations USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0001654954-22-003869
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap ProceedsFromSecuritizationsOfLoansHeldForInvestment Proceeds from Securitizations of Loans Held-for-investment USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0001654954-22-003869
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 977 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -12.29M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 169,897 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 158,904 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 12,280 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001654954-22-015035
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 739,581 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap RestrictedCash Restricted Cash USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 3.20M 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -80.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 74,137 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 160,714 2021-08-01 2021-08-17 2023 Q2 10-Q 2023-08-10 0001654954-23-010487
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 7.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 127,237 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 398,199 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 0 2021-01-01 2021-03-31 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.21 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.009 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 209,915 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 385 2022-09-30 2022 Q3 10-Q 2022-11-10 0001654954-22-015035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023474
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 20,477 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023474
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 5.76 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.83 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award shares 537,750 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-27 0001654954-21-010437
us-gaap SharePrice Share Price USD/shares 1.1 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap SharesIssued Shares, Issued shares 15.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap SharesOutstanding Shares, Outstanding shares 1.90M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001641172-25-023572
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 1.50M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001493152-26-037127
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 3.91M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap StockIssued1 Stock Issued USD 40 2023-01-01 2023-03-31 2023 Q2 10-Q 2023-08-10 0001654954-23-010487
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 363,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001654954-24-014274
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 3.20M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 1.99M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 568,372 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001654954-24-014274
us-gaap SubordinatedBorrowingInterestRate Subordinated Borrowing, Interest Rate pure 0.04 2020-10-01 2020-10-31 2022 FY 10-K 2023-02-21 0001654954-23-001926
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 817 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 53 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001654954-25-002885
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 1.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001493152-26-012992
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 4.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 2.95M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001654954-21-012206
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 4.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001493152-26-050967

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →